TA176: Colorectal cancer (first line) - cetuximab
This is a discussion on TA176: Colorectal cancer (first line) - cetuximab within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Colorectal cancer (first line) - cetuximab. It links to the published guidance and ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA176: Colorectal cancer (first line) - cetuximab
The summary for the published technology appraisal on Colorectal cancer (first line) - cetuximab. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA118: Colorectal cancer (metastatic) - bevacizumab & cetuximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA150: Colorectal cancer (metastatic) - cetuximab (terminated appraisal) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA176: Colorectal cancer (first line) - cetuximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 08-26-2009 12:26 AM |
| First-Line Chemo for Small-Cell Lung Cancer is Not Superior to Second-Line | industry_news | Other Clinical Pharmacy News | 0 | 10-08-2008 09:21 AM |
| Avastin Prolongs Survival in Colorectal Cancer | industry_news | Other Clinical Pharmacy News | 0 | 07-01-2008 02:19 PM |
© 2008 DrugManagementForum™ powered by |
 |